Amgen's strategic growth through M&A and R&D investments has led to a diversified portfolio. Find out why I give AMGN stock a ...

A three-judge panel wrestled Thursday with Novartis AG’s challenge against the FDA over its approval of a generic version of ...

The global cluster headache syndrome market is on an upward trajectory and is anticipated to reach USD 1,042.0 million by 2025. This growth is expected to continue at a steady CAGR of 5.8%, bringing ...